New Methods of Endocrine Management of Prostatic Cancer
- 1 January 1987
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 137 (1) , 1-10
- https://doi.org/10.1016/s0022-5347(17)43855-9
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Isolation and properties of the FSH and LH-releasing hormonePublished by Elsevier ,2004
- Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.BMJ, 1985
- Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.BMJ, 1984
- Treatment of Advanced Prostatic Cancer with Parenteral Cyproterone Acetate: A Phase III Randomised Trial*British Journal of Urology, 1980
- Inhibitory effects of a single intranasal administration of [d-Ser(TBU)6, des-Gly-NH210]LHRK ethylamide, a potent LHRK agonist, on serum steroid levels in normal adult menJournal of Steroid Biochemistry, 1980
- Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissuesJournal of Steroid Biochemistry, 1979
- Treatment of Prostatic Carcinoma with Cyproterone AcetateScandinavian Journal of Urology and Nephrology, 1978
- Megestrol acetate for treatment of advanced carcinoma of the prostateJournal of Surgical Oncology, 1975
- PITUITARY IRRADIATION IN ADVANCED CARCINOMA OF THE PROSTATE: ANALYSIS OF 100 CASESBritish Journal of Urology, 1971
- Prevention of Gynecomastia by Local Roentgen Irradiation in Estrogen-Treated Prostatic CarcinomaScandinavian Journal of Urology and Nephrology, 1969